| The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. | lung, |
| Overexpression of candidate tumor suppressor geneFUS1 isolated from the 3p21.3 homozygous deletionregion leads to G1 arrest and growth inhibition oflung cancer cells. | lung, |
| Myristoylation is required for Fus1-mediated tumor-suppressing activity and suggest a novel mechanism for the inactivation of tumor suppressors in lung cancer. | lung, |
| Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1. | lung, |
| Absence of tumor suppressor FUS1 protein expression is associated with bone and soft tissue sarcomas. | sarcoma, |
| Regulation of tumor suppressor gene FUS1 expression by the untranslated regions of mRNA in human lung cancer cells. | lung, |
| The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner. | lung, |
| FUS1 acts as a tumor-suppressor gene by upregulating miR-197 in human glioblastoma | glioblastoma, |
| These results suggest that miR-378 enhances cell survival, tumor growth, and angiogenesis through repression of the expression of two tumor suppressors, Sufu and Fus-1. | None |
| miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. | None |
| Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunity | None |
| Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers | None |